comprehensive -WSS

comprehensive

author：Wikipedia 2025-10-01 00:58:13 - browse：22581

Joaquin Duato -- health policy coverage from STAT — Johnson & Johnson CEO Joaquin Duato MICHAEL BUHOLZER/AFP via Getty Images

WASHINGTON — Merck CEO Robert Davis and Johnson & Johnson CEO Joaquin Duato have agreed to voluntarily testify before the Senate health committee, avoiding a threatened subpoena, the committee announced Friday.

The decision by the executives came after a public pressure campaign by Sanders to get the two executives and Bristol Myers Squibb CEO Chris Boerner to testify about why prices for their drugs are higher in the United States than in other countries. Sanders had scheduled a vote to subpoena the Merck and Johnson & Johnson CEOs on Jan. 31, but canceled it on Friday.

“The use of a subpoena was clearly a last resort and I’m delighted that these CEOs will be coming into our committee voluntarily,” Sanders said in a written statement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Medicare drug price negotiation program allowed for now

WSS

Ask STAT: What do you want to know about ChatGPT in medicine?

With FDA staff opposed to Sarepta therapy, top official intervened

The science behind Janet Jackson's pregnancy at 49

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

Why drug prescriptions should include diagnoses

focus

comprehensive

explore

Novavax promises a turnaround & Lilly roils the obesity market

STAT's guide to the next generation of CAR

New air purifier tech could be key to improving indoor air quality

Sudafed saga points to U.S. issues with evaluating older drugs

BioMarin wins approval for gene therapy to treat hemophilia A

The battle over the Brookhaven Landfill on Long Island

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The story of mRNA: From a loose idea to a tool that may help curb Covid

Drug repurposing or repositioning? The language matters

FDA advisers vote against ALS treatment from BrainStorm

hotspot

Gene therapy has helped boys walk. Can scientists keep it that way?

Why drug prescriptions should include diagnoses

The science behind Janet Jackson's pregnancy at 49

The battle over the Brookhaven Landfill on Long Island

Paxlovid study fails to answer questions over benefit for broader groups

Data show record exodus of life scientists from academia

focus

leisure time

hotspot

explore